Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line

Anti-Cancer Drug Design

Volumn 11, Issue 1, 1996, Pages 1-14

  Morelli, Susanna ^a   Alama, Angela ^b   Quattrone, Alessandro ^c   Gong, Lei ^a   Copreni, Elena ^a   Canti, Gianfranco ^a   Nicolin, Angelo ^a,d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Institute of Psychology   (Italy)

Author keywords

Apoptosis; B cell lymphoma; bcl 2 gene; Oligodeoxynucleotides; t(14; 18)

Indexed keywords

ANTINEOPLASTIC AGENT; OLIGODEOXYNUCLEOTIDE; PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CELL DEATH; CELL GROWTH; CELL SURVIVAL; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION REGULATION; GENE LOCUS; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYBRID GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; DNA DAMAGE; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, IMMUNOGLOBULIN; HUMANS; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; RNA, NEOPLASM; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029914842     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. ADAMS, J.M. & CORY, s. (1991). Transgenic models of tumor development. Science, 254, 1161.
2. AIELLO, A., DELIA, D., FONTANELLA, E., GIARDINI, R., RILKE, F. & DELLA PORTA, G. (1990). Expression of differentiation and adhesion molecules in sporadic Burkitt's lymphoma. Hematological Oncology, 8, 229.
3. AIELLO, A., DELIA, D., BORRELLO, M., BIASSONI, D., GIARDINI, R., FONTANELLA, E., PEZZELLA, F., PULFORD, K., PIEROTTI, M. & DELLA PORTA, G. (1992). Flow cytometric detection of the mitochondrial Bcl-2 protein in normal and neoplastic human lymphoid cells. Cytometry, 13, 502.
4. ALAMA, A., MEAZZA, R., BARBIERI, F., BIASSONI, R. &. NICOLIN, A. (1993). Antiproliferative effect of DNA polymerase a antisense oligodeoxynucleotides on breast cancer cells. Experimental Cell Research, 206, 318.
5. BISHOP, M.J. (1991). Molecular themes in oncogenesis. Cell, 64, 235.
6. CHEN-LEVY, Z., NOURSE, J. & CLEARY, M.L. (1989). The Bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14; 18) translocation. Molecular and Cellular Biology, 9, 701.
7. CLEARY, M.L., SMITH, S.D. & SKLAR, J. (1986). Cloning and structural analysis of cDNAs for Bcl-2 and a hybrid Bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47, 19.
8. CORY, s. (1986). Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Advances in Cancer Research, 47, 189.
9. COTTER, F.E., JOHNSON, P., HALL, P., POCOCK., C., AL MAHDI, N., COWELL, J.K. & MORGAN, G. (1994). Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model. Oncogene, 9, 3049.
10. DALLA FAVERA, R., BREGNI, M., ERIKSON, J., PATTERSON, D., GALLO, R.C. & CROCE, C.M. (1982). Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proceedings of the National Academy of Sciences (USA), 79, 7824.
11. DENIZOT, F. & LANG, R. (1986). Rapid colorimetric assay for cell growth and survival. Journal of Immunological Methods, 89, 271.
12. DETHÉ, H., LAVAU, C., MARCHIO, A., CHOMIENNE, C., DEGOS, L. & DEJEAN, A. (1991). The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell, 66, 675.
13. DYER, M.J., FISCHER, P., NACHEVA, E., LABASTIDE, W. & KARPAS, A. (1990). A new human B-cell non Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t(14;18) and t(4;11) chromosomal translocation. Blood, 75, 709.
14. EPSTEIN, A.J., LEVY, R., KIM, H., HENLE, G. & KAPLAN, H.S., (1978). Biology of the human B cell lymphomas: IV. Functional characterization of ten histiocytic lymphoma cell lines. Cancer, 42, 2379.
15. FEARON, E.R. & VOGELSTEIN, B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 759.
16. GRAY, J.W. & COFFINO, p. (1979). Cell cycle analysis of flow cytometry. Methods in Enzymology, 58, 233.
17. GU, Y., NAKAMURA, H., ALDER, H., PRASAD, R., CANAANI, O., CIMINO, G., CROCE, C.M. & CANAANI, E. (1992). The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the Af-4 gene. Cell, 71, 701.
18. JACOBSON, M.D., BURNE, J.F., KING, M.P., MIYASHITA, T., REED, J.C. & RAFF, M.C. (1993). Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature, 361, 365.
19. KLUIN-NELEMANS, H.C., LIMPENS, J., MEERABUX, J., BEVERSTOCK, G.C., JANSEN, J.H., DE JONG, D. & KLUIN, P.M. (1991). A new non Hodgkin's B-cell line (DOHH2) with a chromosomal translocation t(14;18)(q(32;21)). Leukemia, 5, 221.
20. KONOPKA, J.B., WATANABE, S.M. & WITTE, O.N. (1984). An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell, 37, 1035.
21. MARX, J. (1989). Many gene changes found in cancer. Science, 246, 1386.
22. MCCARTHY, D.M., RASSOOL, F.V., GOLDMAN, J.M., GRAHAM, S.V. & BIRNIE, G.D. (1984). Genomic alterations involving the c-myc proto-oncogene locus during the evolution of a case of chronic-granulocytic leukaemia. Lancet, ii, 1362.
23. MCDONNELL, T.J.N., DEANE, N., PLATT, F.M., NUNEZ, G., JAEGER, U., MCKEARN, J.P. & KORSMEYER, S.J. (1988). BCL-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57, 79.
24. MCMANAWAY, M.E., NECKERS, L.M., LOKE, S.L., AL-NASSER, A.A., REDNER, R.L., SHIRAMIZU, B.T., GOLDSCHMIDTS, W.L., HUBER, B.E., BHATIA, K. & MAGRATH, I.T. (1990). Tumor-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet, 335, 808.
25. NG, S.Y., GUNNING, P., EDDY, R., PONTE, P., LEAVITT, J., SHOWS, T. & KEDES, L. (1985). Evolution of the functional human β-actin gene and its multipseudogene family: conservation of non-coding regions and chromosomal dispersion of pseudogenes. Molecular and Cellular Biology, 5, 2720.
26. NUNEZ, G., LONDON, L., HOCKENBERRY, D.M., ALEXANDER, M., MCKEARN, J.P. & KORSMEYER, S.J. (1990). Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived haemopoietic cell lines. Journal of Immunology, 144, 3602.
27. PEZZELLA, F., TSE, A.G., CORDELL, J.L., PULFORD, K., GATTER, K.C. & MASON, D.Y. (1990). Expression of the Bcl-2 oncogene protein is not specific for the t(14;18) chromosomal translocation. American Journal of Pathology, 137, 225.
28. POLACK, A., FEEDERLE, R., KLOBECK, G. & HORTNAGEL, K. (1993). Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells. EMBO Journal, 12, 3313.
29. RAIMONDI, S.C (1993). Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood, 81, 2237.
30. REED, J.C., STEIN, C.A., SUBASINGHE, C., HALDAR, S., CROCE, C.M., YUM, S. & COHEN, J.J. (1990). Antisense-mediated inhibition of Bcl-2 proto-oncogene expression and leukemic cell growth and survival: comparison of phosphorodiester and phosphorothioate oligodeoxynucleotides. Cancer Research, 50, 6565.
31. ROWLEY, J.D. (1990). Molecular cytogenetics: Rosetta stone for understanding cancer. Twentyninth G.H.A. Clowes Memorial Award Lecture. Cancer Research, 50, 3816.
32. RYTE, A., MORELLI, S., MAZZEI, M., ALAMA, A., FRANCO, P., CANTI, G. & NICOLIN, A. (1993). Oligonucleotide degradation contributes to resistance to antisense compounds. Anti-Cancer Drug Design, 4, 197.
33. SCOTT SCHMID, D., TITE, J.P. & RUDDLE, N.H. (1986). DNA fragmentation: manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant. Proceedings of the National Academy of Sciences (USA), 83, 1881.
34. STANBRIDGE, E.J. & NOWELL. P.C. (1990). Origins of human cancer revisited. Cell, 63, 867.
35. SZCZYLIK, C., SKORSKI, T., NICOLAIDES, N.C., MANZELLA, L., MALAGUARNERA, L., VENTURELLI, D., GERWIRTZ, A.M. & CALABRETTA, B. (1991). Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science, 253, 562.
36. TKACHUK, D.C., KOHLER, s. & CLEARY, M.L. (1992). Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell, 71, 691.
37. TSUJIMOTO, Y., FINGER, L.R., YUNIS, J.J., NOVELL, p.c. & CROCE, C.M. (1984). Cloning the chromosome breakpoint of neoplastic B-cells with the t(14;18) chromosome translocation. Science, 226, 1097.
38. VAUX, D.L., WEISSMAN, I.L. & KIM, S.K. (1992). Prevention of programmed cell death in Caenorhabditis elegans by human Bcl-2. Science, 258, 1955.
39. WITTE, O.N. (1993). Role of BCR-ABL oncogene in human leukemia: fifteenth Richard and Hinda Rosenthal Foundation award lecture. Cancer Research, 53, 485.
40. YANO, T., SANDER, C.A., ANDRADE, R.E., GAUWERKY, C.E., CROCE, C.M., LONGO, D.L., JAFFE, E.S. & RAFFELD, M. (1993). Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasms. Blood, 82, 1813.
41. ZUTTER, M., HOCKENBERY, D., SILVERMAN, G.A. & KORSMEYER, S.J. (1991). Immunolocalization of the BCL-2 protein within hematopoietic neoplasms. Blood, 78, 1062.